For Customers Careers
Susan Hager
Ms. Hager brings more than 17 years of experience developing results-driven communications campaigns for industrial biotech and life science companies within both the private and public sectors. Her expertise includes corporate communications, investor and media relations, and government affairs in support of complex product marketing and commercialization initiatives. Previously, Ms. Hager was Vice President of Corporate Communications and Government Affairs for Qteros, the developer of a technology platform for the production of cellulosic ethanol for fuel. Ms. Hager served previously as a Director in the Corporate Communications and Investor Relations practice for WCG, a global communications agency, where she created and led the implementation and execution of integrated, strategic communications programs for the firm's clients in the United States and Europe. Ms. Hager has also served as Vice President, Corporate Communications and Investor Relations for Targanta Therapeutics (sold to The Medicines Company), as well as Vice President, Corporate Communications, Investor Relations and Corporate Development for Coley Pharmaceutical Group (sold to Pfizer Inc). She has also held global marketing and communications roles with Bayer HealthCare LLC. Ms. Hager received a B.S. in Biology and an MBA from Northeastern University in Boston, MA.